Your Targeted, High-Impact Platform to Engage Prospective & Existing Clients That Are at the Forefront of CNS Biomarker Innovation
Positioned at the forefront of CNS biomarker innovation, the 3rd Fluid & Imaging Biomarkers in Neuroscience Summit is the only industry-focused forum, dedicated exclusively to advancing the discovery, validation and clinical application of enhanced biomarker technologies for neurodegenerative and neuroinflammatory diseases.
Unlike broader meetings, this summit unites a niche yet highly influential audience actively seeking next-generation solutions in assay development, multi-omics integration, and scalable diagnostic technologies. As a partner, you can gain direct access to key biotech and pharma decision makers discussing their most pressing translational and clinical pain points. If you are looking to increase brand awareness, showcase your unique offerings to the CNS industry and be the go-to solution provider for biomarker and diagnostic capabilities, this is your unrivalled opportunity.
Key Interest Areas
New and improved assay development and validation to enhance accuracy, credibility, and clinical relevance
Highly specific, sensitive and reliable omics platforms to enable comprehensive analysis and reproducibility
Clinically scalable imaging technology for high-resolution, quantitative, and collaborative insights
Precise imaging data-analysis platforms for dependable, concise, and efficient results
Audience Composition
Company Type
Attendee Seniority
2025 Attending Companies Included